News

Filter

Current filters:

EliquisXareltoGenzyme

1 to 9 of 95870 results

Bristol-Myers and Celgene team up to evaluate Opdivo and Abraxane combo

Bristol-Myers and Celgene team up to evaluate Opdivo and Abraxane combo

20-08-2014

US pharma major Bristol-Myers Squibb and biotech firm Celgene are to collaborate on a combination regimen…

AbraxaneBiotechnologyBristol-Myers SquibbCancer treatmentsCelgene Corp.Ministry of Health Labor and WelfareOncologyOpdivoResearchTechnology-based chemotherapyUnited StatesUSA

Daiichi Sankyo initiates testing of etanercept biosimilar in Japan

Daiichi Sankyo initiates testing of etanercept biosimilar in Japan

20-08-2014

Japanese drug major Daiichi Sankyo says it has started the Phase III trial of CHS-0214, an investigational…

Active rheumatoid arthritisAmgenAnti-Arthritics/RheumaticsBiosimilarsBiotechnologyCoherus BioSciencesDaiichi SankyoEnbreletanerceptJapanPharmacologyResearchRheumatoid arthritis

Mood lifts for Medtech in first half of 2014, while Pharma sector faces new struggles

Mood lifts for Medtech in first half of 2014, while Pharma sector faces new struggles

20-08-2014

An M&A frenzy that accounted for nearly $90 billion of equity set the pace for the first half of 2014…

FinancialGlobalJonathan GardnerMergers & AcquisitionsPharmaceutical

AstraZeneca and Mitsubishi Tanabe Pharma to collaborate on diabetic nephropathy

AstraZeneca and Mitsubishi Tanabe Pharma to collaborate on diabetic nephropathy

20-08-2014

Anglo-Swedish drug major AstraZeneca has entered into a three-year research collaboration on diabetic…

AstraZenecaChronic kidney diseaseDiabetesJapanKidney diseasesMitsubishi TanabeNephrology and HepatologyPharmaceuticalResearchSweden

Emergent BioSolutions and MorphoSys to co-develop prostate cancer drug candidate ES414

Emergent BioSolutions and MorphoSys to co-develop prostate cancer drug candidate ES414

20-08-2014

US biopharmaceutical firm Emergent BioSolutions and Germany’s MorphoSys have entered into an agreement…

BiotechnologyEmergent BioSolutionsES414GermanyLicensingMOR209/ES414MorphoSysOncologyProstate cancerUSA

Russia’s Peptogen launches production of innovative CV drugs

Russia’s Peptogen launches production of innovative CV drugs

20-08-2014

Sergei Sobyanin, Mayor of Moscow, has officially launched a new Russian plant for the production of innovative…

Cardio-vascularHeart attacksMoscowPeptogenPharmaceuticalProductionRussiaSergey SobyaninStrogino

Australia’s NHMRC reports on progress to improve clinical trials

Australia’s NHMRC reports on progress to improve clinical trials

20-08-2014

The National Health and Medical Research Council (NHMRC), tasked with implementing a range of initiatives…

AustraliaClinical researchNational Health and Medical Research CouncilPharmaceuticalRegulationResearchTrials portal

Clinigen adds to oncology portfolio with AstraZeneca’s Ethyol

Clinigen adds to oncology portfolio with AstraZeneca’s Ethyol

20-08-2014

UK-based Clinigen Group has acquired the global rights to the oncology support therapy Ethyol (amifostine)…

ClinigenClinigen GroupEthyolLicensingOncologyPharmaceuticalTreatment for head and neck cancerUK

1 to 9 of 95870 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top